Results 211 to 220 of about 283,224 (387)

Interstitial lung disease in a patient treated with 5-fluorouracil and mitomycin C. [PDF]

, 1978
J W L Fielding, Rob Stockley, V S Brookes   +2 more
openalex   +1 more source

Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancer.

Journal of Clinical Oncology, 2015
Eric Van Cutsem, H. Lenz, C. Köhne, V. Heinemann, S. Tejpar, I. Melezínek, F. Beier, C. Stroh, P. Rougier, J. Han van Krieken, F. Ciardiello   +10 more
semanticscholar   +1 more source

Autophagy‐Targeting Nanomedicine: Strike at the Heart of the Cancer via Precise Modulation of Autophagy

Exploration, EarlyView.
This review emphasizes the critical role of autophagy in cancer treatment, highlighting the development of autophagy‐targeting nanomedicines and their applications in combination therapies. It explores how nanoplatforms can effectively regulate autophagy, underscoring the potential of integrating autophagy modulation with other treatment strategies to ...
Zhouyi Sun, Huali Zuo, Kai Zhang, Yang Liu, Qianwen Wang, Qitao Hu, Jiwei Qian, Andreas Lundqvist, Bo Zhang, Weiyu Chen, Zhe Tang   +10 more
wiley   +1 more source

Thymidine labeling index of human breast carcinoma:Enhancement of in vitrolabeling by 5-fluorouracil and 5-fluoro-2′ - deoxyuridine [PDF]

, 1977
John S. Meyer, Rhoda Facher
openalex   +1 more source

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

Journal of Clinical Oncology, 2006
E. Van Cutsem, V. Moiseyenko, S. Tjulandin, A. Majlis, M. Constenla, C. Boni, Adriano Rodrigues, M. Fodor, Y. Chao, E. Voznyi, M. Risse, J. Ajani   +11 more
semanticscholar   +1 more source

Controlled release of 5-fluorouracil from microporous zeolites [PDF]

, 2014
Bouropoulos, Nikolaos, Cox, Paul A., Ewart, Sinead, Fatouros, Dimitrios G., Kachrimanis, Kyriakos, Moschovi, Anastasia Maria, Nikolakis, Vladimiros, Niopas, Ioannis, Siokou, Angeliki, Spanakis, Marios, Sygellou, Lamprini, Theodoropoulos, Dimitrios, Vizirianakis, Ioannis S.   +12 more
core   +1 more source

Gut‐Targeted Nutraceutical Delivery: Engineering Microbiome‐Responsive Nutraceutical Interfaces

Food Bioengineering, EarlyView.
ABSTRACT The gut microbiome plays a central role in maintaining host health, influencing immunity, metabolism, epithelial integrity, and the gut–brain axis. Dysbiosis of this complex microbial ecosystem is implicated in a variety of chronic diseases, including inflammatory bowel disease, metabolic syndrome, and neurological disorders.
Jeyavelkumaran Renukadevi, Muthu Ranjani, Panneerselvam Sneha, Jahir Safiq Hussain, Harikrishnan Shakthi   +4 more
wiley   +1 more source

Modified hepatic arterial infusion chemotherapy protocol for reducing perioperative pain and anesthetic consumption in patients with hepatocellular carcinoma. [PDF]

Quant Imaging Med Surg
Li H, Li Y, Kang W, Xi J, Sun W, Liu Y, Yang Z.   +6 more
europepmc   +1 more source

Natural Products Targeting the EGFR/HER2 Axis in Tumorigenesis: Interpretation of Molecular Mechanisms and Recent Insights Into Synergistic Strategies for Cancer Therapy

Food Frontiers, EarlyView.
Schematic overview illustrating the anticancer mechanisms of selected natural products (resveratrol, quercetin, berberine) targeting EGFR and HER2 signaling pathways in tumor cells. These compounds inhibit receptor activation and downstream oncogenic cascades, including PI3K/Akt/mTOR, MAPK/ERK, and STAT3 pathways.
Iman Ramli, Anna Maria Posadino, Roberta Giordo, Antonio Barberis, Ylenia Spissu, Redouane Lemoui, William N. Setzer, Javad Sharifi‐Rad, Gianfranco Pintus   +8 more
wiley   +1 more source

Case Report: Bowen's disease treated with PD-1 inhibitor and chemotherapy. [PDF]

Front Oncol
Xie X, Chen Q, Zhang J, Peng X.
europepmc   +1 more source